https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

http://www.cellerys.com/  

8952 Schlieren, Wagistrasse 21

Cellerys is a spin-off from University Hospital and University of Zurich. The company develops new therapies against Multiple Sclerosis (MS).

http://www.molecularpartners.com  

8952 Schlieren, Wagistrasse 14

 +41 44 755 77 00

Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.

http://virometix.com  

8952 Schlieren, Wagistrasse 14

 +41 (0)43 433 86 60
 info@virometix.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

https://www.stadt-zuerich.ch/prd/de/index/stadtentwicklung/wirtschaftsfoerderung.html  

8001 Zürich, Stadthaus

The City of Zurich is committed to a sustainable urban and economic development and offers an attractive business environment for established and new companies alike. We foster Zurich's function a as dense knowledge center where companies, startups, research facilities, universities and technical colleges are in close proximity and are able to network and exchange ideas and new business opportunities easily. We facilitate a continuous dialogue between policymakers and the business community and support new companies in establishing the necessary connections to succeed in the diverse Zurich business ecosystem. Our BlueLion incubator offers an acceleration program for startups focusing on Climate Tech and Digital Health. #EconomicDevelopment #BioTechnopark #Zurich #Innovation #Sustainability

http://immunostherapeutics.com/  

8952 Schlieren, Wagistrasse 14

 info@immunostherapeutics.com

ImmunOs Therapeutics AG is a clinical-stage biotechnology company developing the next generation of novel immunotherapies that enhance the efficacy of market leading checkpoint inhibitors and costimulatory agonists for cancer therapy. The company is actively discussing and exploring new strategic collaborations with leading global pharmaceutical companies.

https://vivtex.com/  

8952 Schlieren, Wagistrasse 13

 info@vivtex.com

Vivtex’s proprietary platform enables for the first time the use of intact gastrointestinal tract tissue for fully automated robotic testing. We use this technology to enable the development of new drugs that can be given orally instead of painful and inconvenient needle injections.

https://ghzschlieren.ch/  

8952 Schlieren, Wagistrasse 23

 +41 44 730 83 21
 info@ghzschlieren.ch

The Wagiareal in Schlieren has undergone major construction in recent years. Successful companies in the biotech, communications and administration sectors have established themselves in recent years. The excellently developed real estate optimally supports the companies in achieving their goals. In the future, new office and commercial space for trade, commerce and manufacturing will be created on an ongoing basis. The new projects are being developed in connection with and with synergies of the existing properties. They allow for individual rental space in various sizes, locations and fit-out standards. Not only will you receive suitable space according to your requirements, but we will also take into account your expansion wishes and expansion options. possibilities. Expansion financing, fair rental prices, uncomplicated contract processing and an open ear for our tenants are a matter of course for us.